With the healthcare sector poised to grow significantly in the coming years, healthcare stocks to buy present a fantastic opportunity for investors. Healthcare is something that everyone will need at some point in their lives, so today’s industry of $8.3 trillion spent globally is an indication of a growing, profitable sector – one that could…

Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those areas is among the hottest healthcare stocks. With company-specific catalysts outweighing negative macro factors such as high inflation, rising interest rates, and slowing economic growth, scores…

While it’s tempting to target the flavors of the week during a market correction, investors ought to spare some time for no-brainer blue-chip stocks to buy for 2023 and beyond. Indeed, the broader market and economic dynamics encourage retail investors to think about value and stability over growth. Earlier, I laid out the monetary backdrop…

Teledoc Health (NASDAQ:TDOC) became a Covid-19 pandemic favorite in 2020. Barely a year later, when the stock peaked at $308 earlier this year, TDOC stock faces tremendous headwinds. Momentum investors moved on, leaving Teledoc to prove its acquisition of Livongo will accelerate growth. Source: Piotr Swat / Shutterstock.com Teledoc has a long way to go.…

Value is in the process of reasserting itself. Source: Shutterstock Value will continue to outperform growth. Longer term we want to be exposed to value. Those are three comments the talking heads on CNBC made in April and May on the value vs. growth debate. To be fair, on the surface it looked like value…